Copyright Reports & Markets. All rights reserved.

Global Pirfenidone Sales Market Report 2021

Request for Sample of this report
Buy now

1 Pirfenidone Market Overview

  • 1.1 Pirfenidone Product Scope
  • 1.2 Pirfenidone Segment by Type
    • 1.2.1 Global Pirfenidone Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Tablet
    • 1.2.3 Capsule
    • 1.2.4 Other
  • 1.3 Pirfenidone Segment by Application
    • 1.3.1 Global Pirfenidone Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Mild Idiopathic Pulmonary Fibrosis
    • 1.3.3 Moderate Idiopathic Pulmonary Fibrosis
    • 1.3.4 Other
  • 1.4 Pirfenidone Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Pirfenidone Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Pirfenidone Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Pirfenidone Price Trends (2016-2027)

2 Pirfenidone Estimates and Forecasts by Region

  • 2.1 Global Pirfenidone Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Pirfenidone Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Pirfenidone Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Pirfenidone Revenue Market Share by Region (2016-2021)
  • 2.3 Global Pirfenidone Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Pirfenidone Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Pirfenidone Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Pirfenidone Estimates and Projections (2016-2027)
    • 2.4.2 Europe Pirfenidone Estimates and Projections (2016-2027)
    • 2.4.3 China Pirfenidone Estimates and Projections (2016-2027)
    • 2.4.4 Japan Pirfenidone Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Pirfenidone Estimates and Projections (2016-2027)
    • 2.4.6 India Pirfenidone Estimates and Projections (2016-2027)

3 Global Pirfenidone Competition Landscape by Players

  • 3.1 Global Top Pirfenidone Players by Sales (2016-2021)
  • 3.2 Global Top Pirfenidone Players by Revenue (2016-2021)
  • 3.3 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pirfenidone as of 2020)
  • 3.4 Global Pirfenidone Average Price by Company (2016-2021)
  • 3.5 Manufacturers Pirfenidone Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Pirfenidone Market Size by Type

  • 4.1 Global Pirfenidone Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Pirfenidone Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Pirfenidone Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Pirfenidone Price by Type (2016-2021)
  • 4.2 Global Pirfenidone Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Pirfenidone Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Pirfenidone Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Pirfenidone Price Forecast by Type (2022-2027)

5 Global Pirfenidone Market Size by Application

  • 5.1 Global Pirfenidone Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Pirfenidone Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Pirfenidone Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Pirfenidone Price by Application (2016-2021)
  • 5.2 Global Pirfenidone Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Pirfenidone Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Pirfenidone Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Pirfenidone Price Forecast by Application (2022-2027)

6 North America Pirfenidone Market Facts & Figures

  • 6.1 North America Pirfenidone Sales by Company
    • 6.1.1 North America Pirfenidone Sales by Company (2016-2021)
    • 6.1.2 North America Pirfenidone Revenue by Company (2016-2021)
  • 6.2 North America Pirfenidone Sales Breakdown by Type
    • 6.2.1 North America Pirfenidone Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Pirfenidone Sales Breakdown by Type (2022-2027)
  • 6.3 North America Pirfenidone Sales Breakdown by Application
    • 6.3.1 North America Pirfenidone Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Pirfenidone Sales Breakdown by Application (2022-2027)

7 Europe Pirfenidone Market Facts & Figures

  • 7.1 Europe Pirfenidone Sales by Company
    • 7.1.1 Europe Pirfenidone Sales by Company (2016-2021)
    • 7.1.2 Europe Pirfenidone Revenue by Company (2016-2021)
  • 7.2 Europe Pirfenidone Sales Breakdown by Type
    • 7.2.1 Europe Pirfenidone Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Pirfenidone Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Pirfenidone Sales Breakdown by Application
    • 7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Pirfenidone Market Facts & Figures

  • 8.1 China Pirfenidone Sales by Company
    • 8.1.1 China Pirfenidone Sales by Company (2016-2021)
    • 8.1.2 China Pirfenidone Revenue by Company (2016-2021)
  • 8.2 China Pirfenidone Sales Breakdown by Type
    • 8.2.1 China Pirfenidone Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Pirfenidone Sales Breakdown by Type (2022-2027)
  • 8.3 China Pirfenidone Sales Breakdown by Application
    • 8.3.1 China 316 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Pirfenidone Market Facts & Figures

  • 9.1 Japan Pirfenidone Sales by Company
    • 9.1.1 Japan Pirfenidone Sales by Company (2016-2021)
    • 9.1.2 Japan Pirfenidone Revenue by Company (2016-2021)
  • 9.2 Japan Pirfenidone Sales Breakdown by Type
    • 9.2.1 Japan Pirfenidone Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Pirfenidone Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Pirfenidone Sales Breakdown by Application
    • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pirfenidone Market Facts & Figures

  • 10.1 Southeast Asia Pirfenidone Sales by Company
    • 10.1.1 Southeast Asia Pirfenidone Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Pirfenidone Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Pirfenidone Sales Breakdown by Type
    • 10.2.1 Southeast Asia Pirfenidone Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Pirfenidone Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Pirfenidone Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Pirfenidone Market Facts & Figures

  • 11.1 India Pirfenidone Sales by Company
    • 11.1.1 India Pirfenidone Sales by Company (2016-2021)
    • 11.1.2 India Pirfenidone Revenue by Company (2016-2021)
  • 11.2 India Pirfenidone Sales Breakdown by Type
    • 11.2.1 India Pirfenidone Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Pirfenidone Sales Breakdown by Type (2022-2027)
  • 11.3 India Pirfenidone Sales Breakdown by Application
    • 11.3.1 India Pirfenidone Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Pirfenidone Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pirfenidone Business

  • 12.1 Genentech (Roche)
    • 12.1.1 Genentech (Roche) Corporation Information
    • 12.1.2 Genentech (Roche) Business Overview
    • 12.1.3 Genentech (Roche) Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Genentech (Roche) Pirfenidone Products Offered
    • 12.1.5 Genentech (Roche) Recent Development
  • 12.2 Shionogi
    • 12.2.1 Shionogi Corporation Information
    • 12.2.2 Shionogi Business Overview
    • 12.2.3 Shionogi Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Shionogi Pirfenidone Products Offered
    • 12.2.5 Shionogi Recent Development
  • 12.3 GNI Group
    • 12.3.1 GNI Group Corporation Information
    • 12.3.2 GNI Group Business Overview
    • 12.3.3 GNI Group Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 GNI Group Pirfenidone Products Offered
    • 12.3.5 GNI Group Recent Development
  • 12.4 Beijing Continent
    • 12.4.1 Beijing Continent Corporation Information
    • 12.4.2 Beijing Continent Business Overview
    • 12.4.3 Beijing Continent Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Beijing Continent Pirfenidone Products Offered
    • 12.4.5 Beijing Continent Recent Development
  • 12.5 Cipla
    • 12.5.1 Cipla Corporation Information
    • 12.5.2 Cipla Business Overview
    • 12.5.3 Cipla Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Cipla Pirfenidone Products Offered
    • 12.5.5 Cipla Recent Development
  • 12.6 Lupin Ltd
    • 12.6.1 Lupin Ltd Corporation Information
    • 12.6.2 Lupin Ltd Business Overview
    • 12.6.3 Lupin Ltd Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Lupin Ltd Pirfenidone Products Offered
    • 12.6.5 Lupin Ltd Recent Development
  • 12.7 Zydus Cadila
    • 12.7.1 Zydus Cadila Corporation Information
    • 12.7.2 Zydus Cadila Business Overview
    • 12.7.3 Zydus Cadila Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Zydus Cadila Pirfenidone Products Offered
    • 12.7.5 Zydus Cadila Recent Development
  • 12.8 Glenmark Pharmaceuticals
    • 12.8.1 Glenmark Pharmaceuticals Corporation Information
    • 12.8.2 Glenmark Pharmaceuticals Business Overview
    • 12.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Glenmark Pharmaceuticals Pirfenidone Products Offered
    • 12.8.5 Glenmark Pharmaceuticals Recent Development
  • 12.9 Koye Pharmaceuticals
    • 12.9.1 Koye Pharmaceuticals Corporation Information
    • 12.9.2 Koye Pharmaceuticals Business Overview
    • 12.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Koye Pharmaceuticals Pirfenidone Products Offered
    • 12.9.5 Koye Pharmaceuticals Recent Development
  • 12.10 MSN Laboratories
    • 12.10.1 MSN Laboratories Corporation Information
    • 12.10.2 MSN Laboratories Business Overview
    • 12.10.3 MSN Laboratories Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 MSN Laboratories Pirfenidone Products Offered
    • 12.10.5 MSN Laboratories Recent Development
  • 12.11 Wockhardt
    • 12.11.1 Wockhardt Corporation Information
    • 12.11.2 Wockhardt Business Overview
    • 12.11.3 Wockhardt Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Wockhardt Pirfenidone Products Offered
    • 12.11.5 Wockhardt Recent Development
  • 12.12 Incepta Pharmaceuticals
    • 12.12.1 Incepta Pharmaceuticals Corporation Information
    • 12.12.2 Incepta Pharmaceuticals Business Overview
    • 12.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Incepta Pharmaceuticals Pirfenidone Products Offered
    • 12.12.5 Incepta Pharmaceuticals Recent Development
  • 12.13 Unimed Unihealth
    • 12.13.1 Unimed Unihealth Corporation Information
    • 12.13.2 Unimed Unihealth Business Overview
    • 12.13.3 Unimed Unihealth Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Unimed Unihealth Pirfenidone Products Offered
    • 12.13.5 Unimed Unihealth Recent Development

13 Pirfenidone Manufacturing Cost Analysis

  • 13.1 Pirfenidone Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Pirfenidone
  • 13.4 Pirfenidone Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Pirfenidone Distributors List
  • 14.3 Pirfenidone Customers

15 Market Dynamics

  • 15.1 Pirfenidone Market Trends
  • 15.2 Pirfenidone Drivers
  • 15.3 Pirfenidone Market Challenges
  • 15.4 Pirfenidone Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Pirfenidone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pirfenidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Tablet
    Capsule
    Other

    Segment by Application
    Mild Idiopathic Pulmonary Fibrosis
    Moderate Idiopathic Pulmonary Fibrosis
    Other

    The Pirfenidone market is analysed and market size information is provided by regions (countries). Segment by Application, the Pirfenidone market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Genentech (Roche)
    Shionogi
    GNI Group
    Beijing Continent
    Cipla
    Lupin Ltd
    Zydus Cadila
    Glenmark Pharmaceuticals
    Koye Pharmaceuticals
    MSN Laboratories
    Wockhardt
    Incepta Pharmaceuticals
    Unimed Unihealth

    Buy now